Cell Biology Immune Response Protein Expression Treatment 
Drug Discovery World
NOVEMBER 8, 2023
Helmut Salih, MD, Professor for Translational Immunology, Medical Director, Clinical Collaboration Unit Translational Immunology, University Hospital Tuebingen and DKFZ Heidelberg, Germany; Co-Founder, TWYCE GmbH, on: ‘An optimised IgG-Based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers’.
Codon
APRIL 9, 2023
The CAR-T cells were detectable in 26 out of 27 children after 30 months. Of those, 17 children responded to the treatment, and the 3-year overall survival rate was 60 percent. Biology is the world’s most advanced technology. Nature Cell Biology. Subscribe to learn more. 📜 Papers (* = Recommended.)
Expert insights. Personalized for you.
162 
Let's personalize your content